CHU Hôtel-Dieu — Nantes

Public research footprint of CHU Hôtel-Dieu, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · HCC - Hepatocellular Carcinoma · Metastatic Colorectal Cancer · Smoldering Multiple Myeloma

Recently updated registry entries

NCT01343173 — Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid… (Completed)
NCT04090411 — A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to… (Completed)
NCT04564703 — Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Hôtel-Dieu?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.